Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Fresenius Se S/Adr (FSNUY)

Fresenius Se S/Adr (FSNUY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 33,794,236
  • Shares Outstanding, K 2,252,949
  • Annual Sales, $ 23,625 M
  • Annual Income, $ 509,670 K
  • EBIT $ 2,439 M
  • EBITDA $ 3,742 M
  • 60-Month Beta 0.75
  • Price/Sales 1.39
  • Price/Cash Flow 11.85
  • Price/Book 1.56
  • Price/Earnings ttm 17.39
  • Earnings Per Share ttm 0.88
  • Most Recent Earnings $0.23 on 11/05/25
  • Next Earnings Date 02/25/26 [--]
  • Annual Dividend & Yield (Fwd) 0.19 (1.23%)
  • Most Recent Dividend 0.188 on 05/27/25
  • Sector Medical
  • INDUSTRY GROUPING Medical - Outpatient & Hm Care

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.18
  • Growth Rate Est. (year over year) +554,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.8800 +9.62%
on 01/29/26
15.9400 -4.55%
on 02/20/26
+0.8900 (+6.21%)
since 01/23/26
3-Month
13.4200 +13.38%
on 12/01/25
15.9400 -4.55%
on 02/20/26
+1.3750 (+9.93%)
since 11/25/25
52-Week
9.7800 +55.57%
on 04/09/25
33.9300 -55.16%
on 10/31/25
+5.5295 (+57.09%)
since 02/25/25

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies...

See More

Key Turning Points

3rd Resistance Point 15.7200
2nd Resistance Point 15.5450
1st Resistance Point 15.3800
Last Price 15.2150
1st Support Level 15.0400
2nd Support Level 14.8650
3rd Support Level 14.7000

See More

52-Week High 33.9300
Fibonacci 61.8% 24.7047
Fibonacci 50% 21.8550
Fibonacci 38.2% 19.0053
Last Price 15.2150
52-Week Low 9.7800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar